• About VBL
  • Inflammatory Disease Programs
  • Cancer Programs
  • For Patients
  • For Physicians
  • News Room

 

  • overview
  • presentations
  • publications

Media Contact

Dan Budwick

Pure Communications Inc.

(973) 271-6085

Email

 

Publications

VB-111 Expert Opinion on Biological Therapy

Expert Opinion on Biological Therapy, December 2011
VB-111 for cancer

VB-201 Current Opinion in Lipidology

Current Opinion in Lipidology, December 2010
Modified phospholipids as anti-inflammatory compounds.

VB-201 Journal of Neuroimmunology

Journal of Neuroimmunology, September 2010
A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease.

 

Copyright © 2012 VBL. All rights reserved.

  • contact us
  • |
  • sitemap
  • |
  • privacy
  • |
  • terms
  • |